Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis

References

• Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum. 2011;63(4):863–4.
   PubMedGoogle Scholar
• Wiik A. What you should know about PR3-ANCA. An introduction. Arthritis Res. 2000;2(4):252–4.
   PubMedGoogle Scholar
• Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998;53(3): 743–53.
   PubMed Web of Science ®Google Scholar
• Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol. 1999;111(4):507–13.
   PubMed Web of Science ®Google Scholar
• Csernok E, Holle J, Hellmich B, Willem J, Tervaert C, Kallenberg CG, et al. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Rheumatology (Oxford). 2004;43(2):174–80.
   PubMedGoogle Scholar
• Arranz O, Ara J, Rodriguez R, Quintó L, Font J, Mirapeix E, Darnell A. Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-term clinical follow-up of PR3-ANCA-associated vasculitis patients. Clin Nephrol. 2001;56(4):295–301.
   PubMedGoogle Scholar
• Sun J, Fass DN, Hudson JA, Viss MA, Wieslander J, Homburger HA, Specks U. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes. J Immunol Methods. 1998;211(1–2): 111–23.
   PubMedGoogle Scholar
• Roggenbuck D, Buettner T, Hoffmann L, Schmechta H, Reinhold D, Conrad K. Highsensitivity detection of autoantibodies against proteinase-3 by a novel thirdgeneration enzyme-linked immunosorbent assay. Ann N Y Acad Sci. 2009;1173:41–6.
   PubMedGoogle Scholar
• Holle JU, Csernok E, Fredenhagen G, Backes M, Bremer JP, Gross WL. Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3. Ann Rheum Dis. 2010;69(2):468–9.
   PubMedGoogle Scholar
• Rutgers A, Damoiseaux J, Roozendaal C, Limburg PC, Stegeman CA, Tervaert JW. ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis. J Clin Immunol. 2004;24(4):435–40.
   PubMedGoogle Scholar
• Kaul R, Johnson K, Scholz H, Marr G. Performance of the BioPlex 2200 Autoimmune Vasculitis kit. Autoimmun Rev. 2009;8(3):224–7.
   PubMedGoogle Scholar
• Damoiseaux J, Vaessen M, Knapen Y, Csernok E, Stegeman CA, Van Paassen P, Tervaert JW. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease. Ann N Y Acad Sci. 2007;1109:454–63.
   PubMedGoogle Scholar
• Trevisin M, Pollock W, Dimech W, Savige J. Evaluation of a multiplex flow cytometric immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD). J Immunol Methods. 2008;336(2):104–12.
   PubMedGoogle Scholar
• Damoiseaux J, Dahnrich C, Rosemann A, Probst C, Komorowski L, Stegeman CA, et al. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis. Ann Rheum Dis. 2009; 68(2):228–33.
   PubMedGoogle Scholar
• Ito-Ihara T, Muso E, Kobayashi S, Uno K, Tamura N, Yamanishi Y, et al. A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe. Clin Exp Rheumatol. 2008;26(6):1027–33.
   PubMedGoogle Scholar
• Tanaka R, Takemura M, Sato M, Yamada Y, Nakagawa T, Horibe T, et al. Comparison of chemiluminescence enzyme immunoassay(CLEIA) with ELISA for the determination of anti-cyclic citrullinated antibodies. Clin Chim Acta. 2010; 411(1–2):22–5.
   PubMedGoogle Scholar
• Fujimoto S, Uezono S, Hisanaga S, Fukudome K, Kobayashi S, Suzuki K, et al. Incidence of ANCA-associated primary renal vasculitis in Miyazaki prefecture: the first population-based, retrospective, epidemiologic survey in Japan. Clin J Am Soc Nephrol. 2006;1(5):1016–22.
   PubMedGoogle Scholar
• Watts RA, Scott DG, Jayne DRW, Ito-Ihara T, Muso E, Fujimoto S, et al. Renal vasculitis in Japan and UK—are there differences in epidemiology and clinical phenotype? Nephrol Dial Transplant. 2008;23(12):3928–31.
   PubMedGoogle Scholar
• Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 1990;33(8):1065–7.
   PubMedGoogle Scholar
• Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187–92.
   PubMed Web of Science ®Google Scholar
• Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68(12):1827–32.
   PubMed Web of Science ®Google Scholar
• Lee AS, Finkielman JD, Peikert T, Hummel AM, Viss MA, Specks U. A novel capture- ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases. J Immunol Methods. 2005;307(1–2):62–72.
   PubMedGoogle Scholar
• O’Donnell JL, Hayman MW, Spellerberg MB, McLellan AD, Brooksbank K, Chapman PT, Stamp LK. Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA. Pathology 2007;39(2):258–63.
   PubMedGoogle Scholar
• Vermeersch P, Vervaeke S, Blockmans D, van Hoovels L, Mariën G, Vanmaele H, Bossuyt X. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: comparative analysis of different strategies. Clin Chim Acta. 2008;397(1–2):77–81.
   PubMedGoogle Scholar
• Russell KA, Wiegert E, Schroeder DR, Homburger HA, Specks U. Detection of antineutrophil cytoplasmic antibodies under actual clinical testing conditions. Clin Immunol. 2002;103(2):196–203.
   PubMedGoogle Scholar